News
Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced a corporate
IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and blood cancers while preserving
GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Vifor Pharma announces changes to the Executive Committee as CFO retires
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced that Colin Bond, Chief Financial Officer will retire from the company by the end of December 2021
DGAP-News: Biotest AG: Biotest erhält die Zulassung für Intratect(R) in Frankreich
DGAP-News: Biotest AG: Biotest receives approval for Intratect(R) in France
DGAP-News: MorphoSys AG: Unternehmenskalender 2022
DGAP-News: Biotest AG: Biotest AG opens seventh plasma collection centre in Czech Republic
DGAP-News: Biotest AG: Biotest AG eröffnet 7. Plasmasammelzentrum in Tschechien
DGAP-News: Biotest AG: Biotest beschleunigt die Entwicklung von Trimodulin bei hospitalisierten COVID-19-Patienten mit Bundesmitteln in Höhe von 29 Millionen Euro
DGAP-News: Biotest AG: Biotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR
EnWave Signs Royalty-Bearing Commercial License Agreement and Equipment Purchase Agreement with Nippon Trends Food Services, Inc.
Vancouver, B.C., December 1, 2020. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) announced
EnWave unterzeichnet kostenpflichtige kommerzielle Lizenzvereinbarung und Ausrüstungskaufvertrag mit Nippon Trends Food Services, Inc.
Vancouver, B.C., 1. Dezember 2020. Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab
Nova Mentis Life Science schließt Übernahme von Pilz Bioscience ab
Vancouver, British Columbia – 1. Dezember 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FWB: HN3Q) (OTCPK: LIBFF) („NOVA“ oder das „Unternehmen“) freut sich bekannt zu geben, dass im
Nova Mentis Life Science Completes Acquisition of Pilz Bioscience
Vancouver, British Columbia – December 1, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that, further to its
EnWave Signs Second Equipment Purchase Agreement with Patata Torres to Increase REV™ Manufacturing Capacity by 100kW
Vancouver, B.C., November 30, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) announced
EnWave unterzeichnet zweiten Anlagenkaufvertrag mit Patata Torres um die REV™ Fertigungskapazität um 100kW zu erhöhen
Vancouver, B.C., 30. November 2020
Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab
Sirona Biochem veröffentlicht Schreiben des CEO an die Aktionäre
Vancouver, Canada – November 30, 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to provide an update from the Company’s CEO, Dr. Howard Verrico.
Sirona Biochem Releases CEO Letter to Shareholders
Vancouver, Kanada – 30. November 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (US-OTC: SRBCF) („Sirona“) freut sich, ein Update von Dr. Howard J. Verrico, dem CEO des Unternehmens, zu
True Leaf informiert über aktuellen Stand des Handelsverbots für das Management
Vernon (BC), 23. November 2020. True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FWB: TLA) („True Leaf“ oder das „Unternehmen“) stellt diesen zweiwöchentlichen Statusberichts im Einklang
True Leaf Provides Management Cease Trade Order Update
Vernon, BC - November 23, 2020 - True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLA) (“True Leaf” or the “Company”) is providing a biweekly default status report in accordance with
EnWave unterzeichnet lizenzgebührenpflichtige kommerzielle Lizenz und erhält eine Anzahlung für 70kW REV™ Anlage von NuWave Foods für die Herstellung von haltbaren Backwaren
Vancouver, B.C., 23. November 2020
Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab
EnWave Signs Royalty-Bearing Commercial License and Receives Deposit for 70kW of REV™ Machinery from NuWave Foods for the Production of Shelf-Stable Baked Goods
Vancouver, B.C., November 23, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) announced
Relay Medical & Fio Announce Pilot for COVID-19 Rapid Testing with Lonestar Life Sciences at Rural Hospitals in Texas
November 20, 2020 – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), and Fio Corporation (“Fio”), together Fionet Rapid Response Group (“FRR”) are